Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study

The goal of this observational cross-sectional study is to identify factors associated with severity of acne in Thai transmen receiving masculinizing hormone therapy. The main questions it aims to answer are:

* What are the factors associated with severity of acne in transmen? * Does masculinizing hormone therapy associate with the severity of acne in transmen? Participants will be asked to complete an online questionnaire and allow to take pictures of their face for acne assessment purpose.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acne Acne Vulgaris Acneiform Eruptions Behavior Sebaceous Gland Diseases Sexual Behavior Sexuality Skin Diseases Skin and Connective Tissue Diseases Transgenderism Transsexualism

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University

Ratchathewi, Bangkok, 10400, Thailand

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Transmen who visited the Gender Variation (GenV) Clinic of Ramathibodi Hospital
Transmen who received masculinizing hormone therapy (testosterone)
Transmen who completed an online questionnaire and intentional submit their facial photographs

Exclusion criteria

Refusal to participate
Incomplete questionnaire
Missing photos
Diagnosis of any disorders of sexual differentiation which may have peculiar hormonal effect

Treatment and study plan

Testosterone

Drug

Masculinizing hormone therapy (testosterone) is used in female-to-male transgenders for medical reason.

Other names: Demographic data, acne-related clinical risk factors

Primary outcomes

The severity of acne

Time frame: 1 day (At the time of answering an online questionnaire)

Investigator Global Assessment (IGA) scale for acne

Sponsors and collaborators

Lead sponsor

Mahidol University

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Nov 28, 2023
Registry last updated: Nov 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed